Imunon, Inc. (IMNN) vs Soligenix, Inc. (SNGX)
A side-by-side comparison of Imunon, Inc. and Soligenix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMNN
Imunon, Inc.
$1.21HealthcareDelayed quote: Oct 6, 2026, 3:10 PM EDT
SNGX
Soligenix, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 3:02 PM EDT
Total return — IMNN vs SNGX
growth of $100 · dividends reinvested · last 10yIMNN -100.0% (-55.2%/yr)SNGX -100.0% (-57.6%/yr)IMNN compounded faster over this window
IMNN SNGX
IMNN vs SNGX: by the numbers
- •SNGX is the larger company ($5M vs $5M market cap).
Metrics side by side
Valuation
| Metric | IMNN | SNGX |
|---|---|---|
| P/B ratio | 1.21 | 0.80 |
Profitability
| Metric | IMNN | SNGX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -351.30% | -154.08% |
| ROIC | -126.69% | -161.69% |
Growth (annualized)
| Metric | IMNN | SNGX |
|---|---|---|
| Total return CAGR (5Y) | -63.83% | -72.72% |
Frequently asked
- How have IMNN and SNGX total returns compared?
- Over the past 10 years, IMNN delivered -55.17% and SNGX delivered -57.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.